Rubius Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
C/O Verdolino & Lowey, P.C., 124 Washington Street, Suite 101, Foxboro, Massachusetts

There are no Buy or Sell transactions made by insiders since 8/14/2023

Rubius Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Noubar Afeyan Director, 10%+ Owner May 12, 2022
Francis M. Cuss Director May 12, 2022
Natalie C. Holles Director May 12, 2022
Jonathan Symonds Director May 12, 2022
Maiken Keson-Brookes CLO & Corp. Secretary Jan 29, 2022
Anne Prener Director May 12, 2022
Dannielle Appelhans CEO and President Feb 24, 2023
Laurence A. Turka Chief Scientific Officer Jan 29, 2023
Pablo J. Cagnoni Director Feb 1, 2023
Catherine A. Sohn Director May 12, 2022
David R. Epstein Director May 12, 2022
Jose Carmona Chief Financial Officer Jan 31, 2022
Michael Rosenblatt Director May 12, 2022
Susanne Schaffert Director Jul 29, 2022

Recent Insider Transactions by Companies or Individuals for Rubius Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership